Determining medical decision-making capacity in brain tumor patients: why and how?

BACKGROUND: Brain tumor patients are at high risk of impaired medical decision-making capacity (MDC), which can be ethically challenging because it limits their ability to give informed consent to medical treatments or participation in research. The European Association of Neuro-Oncology Palliative...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurooncol Pract
Autors principals: Pace, Andrea, Koekkoek, Johan A F, van den Bent, Martin J, Bulbeck, Helen J, Fleming, Jane, Grant, Robin, Golla, Heidrun, Henriksson, Roger, Kerrigan, Simon, Marosi, Christine, Oberg, Ingela, Oberndorfer, Stefan, Oliver, Kathy, Pasman, H Roeline W, Le Rhun, Emilie, Rooney, Alasdair G, Rudà, Roberta, Veronese, Simone, Walbert, Tobias, Weller, Michael, Wick, Wolfgang, Taphoorn, Martin J B, Dirven, Linda
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Reviews
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7716185/
https://ncbi.nlm.nih.gov/pubmed/33312674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npaa040
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars